VAERS reports by lot

GSK Varicella/Shingles lot M95T2: VAERS reports

52 VAERS reports list lot M95T2 as a GSK Varicella/Shingles vaccine, received between 2019-07-21 and 2021-06-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
52
Reports
4%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5734%
Injection-site / Local reaction3319%
Musculoskeletal2112%
Neurological2012%
Dermatological (non-injection-site)1811%
Allergic / Anaphylactic74%
Gastrointestinal64%
Cardiac / Cardiovascular53%
Respiratory21%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York6
New Jersey5
Pennsylvania5
Illinois5
North Carolina3
Minnesota3
Florida2
Alabama2
Colorado2
Indiana2
Ohio2
South Carolina2

Reports by month received

2019-0712
2019-0820
2019-097
2019-107
2019-122
2020-021
2020-091
2020-111
2021-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.